Xtant Medical stock listed on NYSE MKT: 3 key notes

Written by Anuja Vaidya | October 20, 2015 | Print  |

Xtant Medical's common stock has been approved for listing on the NYSE MKT stock exchange.

Here are three key notes:

 

1. The company's common stock began trading under the symbol "XTNT" on Oct. 19.

 

2. Xtant Medical develops, manufactures and markets regenerative medicine products and medical devices for domestic and international markets.

 

3. Xtant Medical recently participated in the North American Spine Society annual meeting in October and showcased its X-spine and Bacterin product portfolios at the meeting.

 

More articles on devices:
Soft Tissue Regeneration launches L-C Ligament clinical trial — 5 takeaways
Dr. Charles Brooker implants permanent spinal cord stimulator in Australia: 5 things to know
InVivo's pilot study expands to 10 spinal cord injury patients — 5 key notes

© Copyright ASC COMMUNICATIONS 2019. Interested in LINKING to or REPRINTING this content? View our policies here.

Top 40 Articles from the Past 6 Months